These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 26566930)

  • 1. Quality of outcome reporting in phase II studies in pulmonary tuberculosis.
    Bonnett LJ; Davies GR
    Trials; 2015 Nov; 16():518. PubMed ID: 26566930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of reporting of outcomes in phase III studies of pulmonary tuberculosis: a systematic review.
    Bonnett LJ; Ken-Dror G; Davies GR
    Trials; 2018 Feb; 19(1):134. PubMed ID: 29467027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing the Efficacy of Drug Regimens for Pulmonary Tuberculosis: Meta-analysis of Endpoints in Early-Phase Clinical Trials.
    Bonnett LJ; Ken-Dror G; Koh GCKW; Davies GR
    Clin Infect Dis; 2017 Jul; 65(1):46-54. PubMed ID: 28402396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chinese herbal medicine as adjuvant treatment to chemotherapy for multidrug-resistant tuberculosis (MDR-TB): A systematic review of randomised clinical trials.
    Wang M; Guan X; Chi Y; Robinson N; Liu JP
    Tuberculosis (Edinb); 2015 Jul; 95(4):364-72. PubMed ID: 25861717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sputum culture conversion with moxifloxacin-containing regimens in the treatment of patients with newly diagnosed sputum-positive pulmonary tuberculosis in South India.
    Velayutham BV; Allaudeen IS; Sivaramakrishnan GN; Perumal V; Nair D; Chinnaiyan P; Paramasivam PK; Dhanaraj B; Santhanakrishnan RK; Navaneethapandian GP; Marimuthu MK; Kumar V; Kandasamy C; Dharuman K; Elangovan T; Narasimhan M; Rathinam S; Vadivelu G; Rathinam P; Chockalingam C; Jayabal L; Swaminathan S; Shaheed JM
    Clin Infect Dis; 2014 Nov; 59(10):e142-9. PubMed ID: 25028463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moxifloxacin plus standard first-line therapy in the treatment of pulmonary tuberculosis: A meta-analysis.
    Chen Z; Liang JQ; Wang JH; Feng SS; Zhang GY
    Tuberculosis (Edinb); 2015 Jul; 95(4):490-6. PubMed ID: 25964137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Fluroquinolones in Newly Diagnosed, Sputum-Positive Tuberculosis Therapy: A Systematic Review and Network Meta-Analysis.
    Li D; Wang T; Shen S; Cheng S; Yu J; Zhang Y; Zhang C; Tang H
    PLoS One; 2015; 10(12):e0145066. PubMed ID: 26669635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes in randomised controlled trials in prevention and management of carious lesions: a systematic review.
    Levey C; Innes N; Schwendicke F; Lamont T; Göstemeyer G
    Trials; 2017 Nov; 18(1):515. PubMed ID: 29096680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methodological issues in the design of clinical trials for the treatment of multidrug-resistant tuberculosis: challenges and opportunities.
    Lienhardt C; Davies G
    Int J Tuberc Lung Dis; 2010 May; 14(5):528-37. PubMed ID: 20392344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Provisional CDC guidelines for the use and safety monitoring of bedaquiline fumarate (Sirturo) for the treatment of multidrug-resistant tuberculosis.
    Centers for Disease Control and Prevention
    MMWR Recomm Rep; 2013 Oct; 62(RR-09):1-12. PubMed ID: 24157696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substitution of ethambutol with linezolid during the intensive phase of treatment of pulmonary tuberculosis: study protocol for a prospective, multicenter, randomized, open-label, phase II trial.
    Lee JY; Kim DK; Lee JK; Yoon HI; Jeong I; Heo E; Park YS; Lee JH; Park SS; Lee SM; Lee CH; Lee J; Choi SM; Park JS; Joh JS; Cho YJ; Lee YJ; Kim SJ; Hwang YR; Kim H; Ki J; Choi H; Han J; Ahn H; Hahn S; Yim JJ
    Trials; 2017 Feb; 18(1):68. PubMed ID: 28193240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of high-dose rifampin in patients with new, smear-positive tuberculosis (HIRIF): study protocol for a randomized controlled trial.
    Milstein M; Lecca L; Peloquin C; Mitchison D; Seung K; Pagano M; Coleman D; Osso E; Coit J; Vargas Vasquez DE; Sanchez Garavito E; Calderon R; Contreras C; Davies G; Mitnick CD
    BMC Infect Dis; 2016 Aug; 16(1):453. PubMed ID: 27567500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An updated systematic review and meta-analysis for treatment of multidrug-resistant tuberculosis.
    Bastos ML; Lan Z; Menzies D
    Eur Respir J; 2017 Mar; 49(3):. PubMed ID: 28331031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical development of anti-tuberculosis drugs.
    Mitchison DA
    J Antimicrob Chemother; 2006 Sep; 58(3):494-5. PubMed ID: 16840430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB.
    Sharma SK; Sharma A; Kadhiravan T; Tharyan P
    Evid Based Child Health; 2014 Mar; 9(1):169-294. PubMed ID: 25404581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of surgery on the outcome of treatment for multidrug-resistant tuberculosis: a systematic review and meta-analysis.
    Harris RC; Khan MS; Martin LJ; Allen V; Moore DA; Fielding K; Grandjean L;
    BMC Infect Dis; 2016 Jun; 16():262. PubMed ID: 27283524
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.